Literature DB >> 10566638

Vitamin D supplementation in postmenopausal black women.

M Kyriakidou-Himonas1, J F Aloia, J K Yeh.   

Abstract

Black women have lower levels of serum 25-hydroxyvitamin D (25OHD) with higher serum PTH levels than white women. Correction of these alterations in the vitamin D-endocrine system could lead to less bone loss in postmenopausal women and, consequently, preservation of bone mass. Ten healthy postmenopausal black women were given 20 microg vitamin D3 daily for 3 months. At the end of the study, mean serum 25OHD levels had increased from 24 to 63 nmol/L. Serum intact PTH and nephrogenous cAMP declined significantly, and there was a 21% drop in the fasting urinary N-telopeptide of type I collagen. Vitamin D3 supplementation raises serum 25OHD levels in postmenopausal black women, decreases secondary hyperparathyroidism, and reduces bone turnover. These findings should spur further investigation of the use of vitamin D supplementation in the prevention of osteoporosis in this population.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10566638     DOI: 10.1210/jcem.84.11.6132

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  Randomized trial assessing the effects of ergocalciferol administration on circulating FGF23.

Authors:  Sherri-Ann M Burnett-Bowie; Benjamin Z Leder; Maria P Henao; Chantel M Baldwin; Douglas L Hayden; Joel S Finkelstein
Journal:  Clin J Am Soc Nephrol       Date:  2012-02-02       Impact factor: 8.237

2.  Effects of vitamin D insufficiency on bone mineral density in African American men.

Authors:  N Akhter; B Sinnott; K Mahmood; S Rao; S Kukreja; E Barengolts
Journal:  Osteoporos Int       Date:  2008-09-27       Impact factor: 4.507

3.  A randomized controlled trial of vitamin D3 supplementation in African American women.

Authors:  John F Aloia; Sonia Arunabh Talwar; Simcha Pollack; James Yeh
Journal:  Arch Intern Med       Date:  2005-07-25

4.  The relationship of Physical performance and Osteoporosis prevention with vitamin D in older African Americans (PODA).

Authors:  Ruban Dhaliwal; Mageda Mikhail; Gianina Usera; Alexandra Stolberg; Shahidul Islam; Louis Ragolia; John F Aloia
Journal:  Contemp Clin Trials       Date:  2017-12-06       Impact factor: 2.226

Review 5.  The role of vitamin D in cancer prevention.

Authors:  Cedric F Garland; Frank C Garland; Edward D Gorham; Martin Lipkin; Harold Newmark; Sharif B Mohr; Michael F Holick
Journal:  Am J Public Health       Date:  2005-12-27       Impact factor: 9.308

6.  Baseline levels determine magnitude of increment in 25 hydroxy vitamin D following vitamin D3 prescription in healthy subjects.

Authors:  Mahmoud Ali Kaykhaei; Mahdieh Khodadoost; Ali Reza Dashipour; Zahra Haidari; Azra Karimkoshteh; Mahnaz Sandoughi
Journal:  Endocrine       Date:  2019-03-14       Impact factor: 3.633

7.  Prevalence of vitamin D3 deficiency in orange county residents.

Authors:  Moiz Horani; Azriel Dror; Dustin Holland; Fred Caporaso; Ken D Sumida; Frank Frisch
Journal:  J Community Health       Date:  2011-10

8.  New perspectives on vitamin D sources in Germany based on a novel mathematical bottom-up model of 25(OH)D serum concentrations.

Authors:  Jonathan Brown; Anita Ignatius; Michael Amling; Florian Barvencik
Journal:  Eur J Nutr       Date:  2012-12-11       Impact factor: 5.614

Review 9.  Optimal vitamin D status for the prevention and treatment of osteoporosis.

Authors:  Michael F Holick
Journal:  Drugs Aging       Date:  2007       Impact factor: 3.923

10.  25-Hydroxyvitamin D response to cholecalciferol supplementation in hemodialysis.

Authors:  Laura A G Armas; Radha Andukuri; Janet Barger-Lux; Robert P Heaney; Richard Lund
Journal:  Clin J Am Soc Nephrol       Date:  2012-07-12       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.